LCI News and Press, Lannett Co Inc From 04/06/21

Lannett (LCI) announces that it intends to offer $350M aggregate principal amount of senior secured notes due 2026.The notes will mature in April 2026, and are expected to bear interest that will be payable semiannually.Intends to use the net proceeds, together with other borrowings under a s...

Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026 PR Newswire PHILADELPHIA , April 6, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company") today announced that it intends to offer, subject to market conditions and oth...

Lannett Submits ANDA For Generic ADVAIR DISKUS® PR Newswire PHILADELPHIA , April 1, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the submission of an Abbreviated New Drug Application (ANDA) for Fluticasone propionate and Salmet...

Lannett Company (LCI) has announced that it received feedback from the FDA on the development work related to biosimilar insulin glargine.At a Biosimilar Biological Product Development Type 2 meeting held in June 2020, the FDA has requested the company to submit a protocol for the p...

Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance --FDA Provides Feedback on Pivotal Trial Protocol and Statistical Analysis Plan-- PR Newswire PHILADELPHIA , March 10, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) ...

Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin --Lannett and HEC to Co-develop Insulin Aspart; Lannett Granted Exclusive US Commercialization Rights-- PR Newswire PHILADELPHIA , Feb. 9, 2021 /PRNewswire/ -- Lannett Compa...

Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets PR Newswire PHILADELPHIA , Feb. 8, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has begun marketing Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 25 mg, 50 mg...

Generic drug manufacturer Lannett (NYSE: LCI) released its financial results for the second quarter of its fiscal year 2021 -- which ended on Dec. 31, 2020 -- after the market closed on Wednesday. And although the company's performance was in line with or above expectations, investo...

Gainers: ATA Creativity Global (AACG) +204%.Anavex Life Sciences (AVXL) +81%.Lizhi (LIZI) +76%.CPS Technologies (CPSH) +48%.Annovis Bio (ANVS) +43%.Sify Technologies (SIFY) +42%.Tian Ruixiang (TIRX) +40%.Cyclerion Therapeutics (CYCN) +39%.Cyclo Therapeutics (CYTH) +33%.Ato...

Gainers: Anavex Life Sciences (AVXL) +94%, Annovis Bio (ANVS) +50%, Atossa Therapeutics (ATOS) +40%, Cyclerion Therapeutics (CYCN) +40%, Cyclo Therapeutics (CYTH) +33%.Losers: Tyme Technologies (TYME) -36%, Isoray (ISR) -19%, Lannett...